Hemostasis
What we do

We develop, manufacture and distribute the highest quality, and most innovative systems, reagents and data management solutions for Hemostasis diagnostics. Our solutions help hospitals, hospital networks and commercial laboratories ensure quality results and enhance efficiency.

How we power patient care

As the world leader in Hemostasis, our portfolio of Diagnostic Management solutions powers the care clinicians provide to patients with bleeding and thrombotic disorders. Accurate, reliable results, received quickly, help inform key patient management decisions clinicians make every day.

Hemostasis


A year of growth, expansion and key innovations
For Hemostasis, 2024 was a year of excellent business growth across product lines and geographies, coupled with the commercialization of key innovations. Of note, we commercially launched our new flagship product line, the ACL TOP Family 70 Series Hemostasis Testing Systems, in the USA. A standardized family of top-of-the-line systems, ACL TOP 70 Series systems deliver significant workflow optimization to the lab. This innovation has the potential to enhance both efficiency and patient care in hospitals and commercial laboratories around the world, as global commercialization expands.
In December, we opened a new building, expanding our Innovation capabilities in Specialized Diagnostics, at our Hemostasis and Acute Care Diagnostics Technology Center in Bedford, MA. This adds 105,000 additional square feet and represents an investment of more than US$ 50 million. It also will increase our capacity from 1,200 employees today, to 2,000 employees, allowing growth in our innovation program for several years to come.